Cancer
Showing NaN - NaN of 39
Cancer Trial in Worldwide (Trametinib (GSK1120212), Docetaxel, Erlotinib)
Completed
- Cancer
- Trametinib (GSK1120212)
- +6 more
-
Scottsdale, Arizona
- +19 more
Nov 8, 2017
Breast Carcinoma, Cancer, Fatigue Trial in United States (Omega-3 Fatty Acid, Placebo, Questionnaire Administration)
Completed
- Breast Carcinoma
- +2 more
- Omega-3 Fatty Acid
- +3 more
-
Wichita, Kansas
- +5 more
Jul 5, 2017
Fatigue, Cancer, Sleep Disorders Trial in United States (Standard Care Control Condition, Yoga Intervention (YOCAS))
Completed
- Fatigue
- +2 more
- Standard Care Control Condition
- Yoga Intervention (YOCAS)
-
Decatur, Illinois
- +10 more
Jan 3, 2017
Cancer Trial in United States (CGC-11047 and gemcitabine, CGC-11047 and docetaxel, CGC-11047 and bevacizumab)
Completed
- Cancer
- CGC-11047 and gemcitabine
- +6 more
-
Denver, Colorado
- +11 more
Jun 21, 2016
Melanoma, Cancer Trial in Canada, United States (ALVAC(2) Melanoma multi-antigen therapeutic vaccine, Intron A, Interferon alpha
Terminated
- Melanoma
- Cancer
- ALVAC(2) Melanoma multi-antigen therapeutic vaccine
- Intron A, Interferon alpha -2b
-
Tucson, Arizona
- +18 more
Apr 12, 2016
Pain, Cancer Trial in United States (OraVescent fentanyl (OVF))
Completed
- Pain
- Cancer
- OraVescent fentanyl (OVF)
-
Cullman, Alabama
- +25 more
May 8, 2014
Cancer Trial in United States (Oral lapatinib tablets or tablets)
Terminated
- Cancer
- Oral lapatinib tablets or placebo tablets
-
Denver, Colorado
- +19 more
Jun 7, 2012